Bivision Biomedical Technology (Nanjing) Co., Ltd.
PrivateLast Round
Series B
May 19, 2026
Total Funding Raised
$99.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bivision Biomedical Technology (Nanjing) Co., Ltd. is a biopharmaceutical company that develops radiopharmaceutical therapies for the treatment and diagnosis of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bivision Biomedical Technology (Nanjing) Co., Ltd. Comparables
Compare Bivision Biomedical Technology (Nanjing) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| C-Ray Therapeutics | 86% | |
| Suzhou SmartNuclide Biopharmaceutical Co., Ltd. | 86% | |
| ARTBIO | 85% | |
Bivision Biomedical Technology (Nanjing) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 19, 2026 | ||||
| Series A Extension | Jan 17, 2025 | ||||
| Series A | Jul 26, 2024 | ||||
| Angel | Aug 10, 2022 | ||||
| Seed | Sep 1, 2021 |
Bivision Biomedical Technology (Nanjing) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series B |
| Kaitai Capital | Angel, Seed |
| Lichen Capital | Series A, Angel |
| Wuxi Capital Group Co.,Ltd | Series B |
| Yijing Capital | Seed |
| Guohai Innovation Capital Investment Management | Series B |
| Gaorong Capital | Series B, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
$57M round led by IDG Capital
- Jan 17, 2025
Raised $14M led by CICC NOSG Fund.
Bivision Biomedical Technology (Nanjing) Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bivision Biomedical Technology (Nanjing) Co., Ltd.'s valuation, stock price, and market status.